Early Growth Response 2 (EGR2) is a Novel Regulator of the Senescence Programme

Overview

Journal Aging Cell

Specialties Cell Biology
Geriatrics

Date 2021 Feb 6

PMID 33547862

Citations 15

Authors

Eleanor J Tyler

Ana Gutierrez Del Arroyo

Bethany K Hughes

Ryan Wallis

James C Garbe

Martha R Stampfer

Jim Koh

Robert Lowe

Michael P Philpott

Cleo L Bishop

Affiliations

Soon will be listed here.

Abstract

Senescence, a state of stable growth arrest, plays an important role in ageing and age-related diseases in vivo. Although the INK4/ARF locus is known to be essential for senescence programmes, the key regulators driving p16 and ARF transcription remain largely underexplored. Using siRNA screening for modulators of the p16/pRB and ARF/p53/p21 pathways in deeply senescent human mammary epithelial cells (DS HMECs) and fibroblasts (DS HMFs), we identified EGR2 as a novel regulator of senescence. EGR2 expression is up-regulated during senescence, and its ablation by siRNA in DS HMECs and HMFs transiently reverses the senescent phenotype. We demonstrate that EGR2 activates the ARF and p16 promoters and directly binds to both the ARF and p16 promoters. Loss of EGR2 down-regulates p16 levels and increases the pool of p16- p21- 'reversed' cells in the population. Moreover, EGR2 overexpression is sufficient to induce senescence. Our data suggest that EGR2 is a direct transcriptional activator of the p16/pRB and ARF/p53/p21 pathways in senescence and a novel marker of senescence.

Citing Articles

Manual Therapy Improves Fibromyalgia Symptoms by Downregulating .

Bonastre-Ferez J, Gimenez-Orenga K, Falaguera-Vera F, Garcia-Escudero M, Oltra E Int J Mol Sci. 2024; 25(17).

PMID: 39273470 PMC: 11394909. DOI: 10.3390/ijms25179523.

Valproic acid-induced teratogenicity is driven by senescence and prevented by Rapamycin in human spinal cord and animal models.

Pietrogrande G, Shaker M, Stednitz S, Soheilmoghaddam F, Aguado J, Morrison S Mol Psychiatry. 2024; 30(3):986-998.

PMID: 39227432 PMC: 11835743. DOI: 10.1038/s41380-024-02732-0.

Cellular senescence and SASP in tumor progression and therapeutic opportunities.

Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F Mol Cancer. 2024; 23(1):181.

PMID: 39217404 PMC: 11365203. DOI: 10.1186/s12943-024-02096-7.

An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo.

Lujan C, Tyler E, Ecker S, Webster A, Stead E, Martinez-Miguel V Genome Med. 2024; 16(1):85.

PMID: 38956711 PMC: 11218148. DOI: 10.1186/s13073-024-01349-w.

Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.

Xiang K, Wang E, Mantyh J, Rupprecht G, Negrete M, Sanati G Adv Sci (Weinh). 2024; 11(16):e2303379.

PMID: 38380561 PMC: 11040356. DOI: 10.1002/advs.202303379.

References

Ohtani N, Zebedee Z, Huot T, Stinson J, Sugimoto M, Ohashi Y . Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001; 409(6823):1067-70. DOI: 10.1038/35059131. View

Srinivasan R, Sun G, Keles S, Jones E, Jang S, Krueger C . Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res. 2012; 40(14):6449-60. PMC: 3413122. DOI: 10.1093/nar/gks313. View

Zhang Y, Xiong Y, Yarbrough W . ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998; 92(6):725-34. DOI: 10.1016/s0092-8674(00)81401-4. View

Garbe J, Bhattacharya S, Merchant B, Bassett E, Swisshelm K, Feiler H . Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res. 2009; 69(19):7557-68. PMC: 2782785. DOI: 10.1158/0008-5472.CAN-09-0270. View

Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M . Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 2007; 21(22):2923-35. PMC: 2049194. DOI: 10.1101/gad.450107. View

Yalcin S, Zhang X, Luciano J, Mungamuri S, Marinkovic D, Vercherat C . Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem. 2008; 283(37):25692-25705. DOI: 10.1074/jbc.M800517200. View

Safka Brozkova D, Nevsimalova S, Mazanec R, Rautenstrauss B, Seeman P . Charcot-Marie-Tooth neuropathy due to a novel EGR2 gene mutation with mild phenotype--usefulness of human mapping chip linkage analysis in a Czech family. Neuromuscul Disord. 2012; 22(8):742-6. DOI: 10.1016/j.nmd.2012.04.002. View

Bishop C, Bergin A, Fessart D, Borgdorff V, Hatzimasoura E, Garbe J . Primary cilium-dependent and -independent Hedgehog signaling inhibits p16(INK4A). Mol Cell. 2010; 40(4):533-47. DOI: 10.1016/j.molcel.2010.10.027. View

Carvalho C, LHote V, Courbeyrette R, Kratassiouk G, Pinna G, Cintrat J . Glucocorticoids delay RAF-induced senescence promoted by EGR1. J Cell Sci. 2019; 132(16). DOI: 10.1242/jcs.230748. View

10.

Lowe R, Overhoff M, Ramagopalan S, Garbe J, Koh J, Stampfer M . The senescent methylome and its relationship with cancer, ageing and germline genetic variation in humans. Genome Biol. 2015; 16:194. PMC: 4574115. DOI: 10.1186/s13059-015-0748-4. View

11.

Gil J, Peters G . Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol. 2006; 7(9):667-77. DOI: 10.1038/nrm1987. View

12.

Borgdorff V, LLeonart M, Bishop C, Fessart D, Bergin A, Overhoff M . Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene. 2010; 29(15):2262-71. DOI: 10.1038/onc.2009.497. View

13.

Beckmann A, Wilce P . Egr transcription factors in the nervous system. Neurochem Int. 1997; 31(4):477-510; discussion 517-6. DOI: 10.1016/s0197-0186(96)00136-2. View

14.

Alcorta D, Xiong Y, Phelps D, Hannon G, Beach D, Barrett J . Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A. 1996; 93(24):13742-7. PMC: 19411. DOI: 10.1073/pnas.93.24.13742. View

15.

Gutierrez Del Arroyo A, El Messaoudi S, Clark P, James M, Stott F, Bracken A . E2F-dependent induction of p14ARF during cell cycle re-entry in human T cells. Cell Cycle. 2007; 6(21):2697-705. DOI: 10.4161/cc.6.21.4857. View

16.

Sharpless N, Sherr C . Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15(7):397-408. DOI: 10.1038/nrc3960. View

17.

Hari P, Millar F, Tarrats N, Birch J, Quintanilla A, Rink C . The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci Adv. 2019; 5(6):eaaw0254. PMC: 6551188. DOI: 10.1126/sciadv.aaw0254. View

18.

Serrano M, Lin A, McCurrach M, Beach D, Lowe S . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593-602. DOI: 10.1016/s0092-8674(00)81902-9. View

19.

Baker D, Wijshake T, Tchkonia T, LeBrasseur N, Childs B, van de Sluis B . Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479(7372):232-6. PMC: 3468323. DOI: 10.1038/nature10600. View

20.

Unoki M, Nakamura Y . Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity. FEBS Lett. 2003; 554(1-2):67-72. DOI: 10.1016/s0014-5793(03)01092-5. View